Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 34Carcinoma, Non-Small-Cell Lung 15Breast Neoplasms 13Neoplasm Metastasis 9Triple Negative Breast Neoplasms 6Neoplasms 5Sarcoma 3Lymphoma, Non-Hodgkin 3Lung Neoplasms 3Hodgkin Disease 3Carcinoma, Squamous Cell 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Multiple Myeloma 2Melanoma 2Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Pancreatic Ductal 2Carcinoma 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Urinary Bladder Neoplasms 1Thrombocytosis 1Thoracic Neoplasms 1Squamous-Cell Non-Small-Cell Lung Cancer 1Spinal Cord Compression 1Solid Tumor 1

Interventions

ensituximab 1Gemcitabine 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pancreatic cancer, adult × 130-nm albumin-bound paclitaxel × Clear all
NCT01834235 2025-05-07

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Precision Biologics, Inc

Phase 1/2 Terminated
81 enrolled 13 charts
Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡